LifeStance Health Group, Inc. (LFST) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2026
Loading P/E history...
LFST Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, LifeStance Health Group, Inc. (LFST) trades at a price-to-earnings ratio of 442.5x, with a stock price of $8.85 and trailing twelve-month earnings per share of $0.06.
The current P/E is 92% above its 5-year average of 230.7x. Over the past five years, LFST's P/E has ranged from a low of 109.5x to a high of 352.0x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, LFST trades at a 1882% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, LFST commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our LFST DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
LFST P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $11B | 7.4Lowest | 0.46 | +37% | |
| $3B | 16.3 | - | +3% | |
| $10B | 29.8 | 2.16 | +14% | |
| $868M | 129.5 | - | - | |
| $5B | 23.5 | 0.30Best | +54%Best | |
| $7B | 50.3 | - | -4% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
LFST Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $6.37 | $0.06 | 109.5x | -53% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $7.04 | $0.02 | 352.0x | +53% |
Average P/E for displayed period: 230.7x
See LFST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFST vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLFST — Frequently Asked Questions
Quick answers to the most common questions about buying LFST stock.
Is LFST stock overvalued or undervalued?
LFST trades at 442.5x P/E, above its 5-year average of 230.7x. The 100th percentile ranking indicates a premium to historical valuation.
How does LFST's valuation compare to peers?
LifeStance Health Group, Inc. P/E of 442.5x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is LFST's PEG ratio?
LFST PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2026.